Katarzyna Bogunia-Kubik (K Bogunia-Kubik)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Rheumatoid Arthritis

Disease Activity

Prognostic Factors

Top Venues

Archivum immunologiae et therapiae experimentalis

Immunologic research

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sylwia Biały, Milena Iwaszko, Jerzy Świerkot, Katarzyna Kolossa, Joanna Wielińska, Sławomir Jeka, Katarzyna Bogunia-Kubik
Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis. Immunologic research 72 (4) (2024)
Sylwia Biały, Milena Iwaszko, Jerzy Świerkot, Katarzyna Kolossa, Joanna Wielińska, Sławomir Jeka, Katarzyna Bogunia-Kubik
Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis. Immunologic research 72 (4) (2024)
Sylwia Biały, Milena Iwaszko, Jerzy Świerkot, Katarzyna Kolossa, Joanna Wielińska, Sławomir Jeka, Katarzyna Bogunia-Kubik
Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis. Immunologic research 72 (4) (2024)
Sylwia Biały, Milena Iwaszko, Jerzy Świerkot, Katarzyna Kolossa, Joanna Wielińska, Sławomir Jeka, Katarzyna Bogunia-Kubik
Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis. Immunologic research (2024)
Jagoda Siemaszko, Aleksandra Marzec-Przyszlak, Katarzyna Bogunia-Kubik
Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications. Archivum immunologiae et therapiae experimentalis 71 (1) (2023)
Jagoda Siemaszko, Aleksandra Marzec-Przyszlak, Katarzyna Bogunia-Kubik
Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications. Archivum immunologiae et therapiae experimentalis 71 (1) (2023)
Jagoda Siemaszko, Aleksandra Marzec-Przyszlak, Katarzyna Bogunia-Kubik
Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications. Archivum immunologiae et therapiae experimentalis 71 (1) (2023)
Bartosz Bugaj, Joanna Wielinska, Katarzyna Bogunia-Kubik, Jerzy Świerkot
Searching for New Genetic Biomarkers of Axial Spondyloarthritis. Journal of clinical medicine 11 (10) (2022)
Piotr Macek, Mieszko Więckiewicz, Rafal Poreba, Pawel Gac, Katarzyna Bogunia-Kubik, Marta Dratwa, Anna Wojakowska, Grzegorz Mazur, Helena Martynowicz
Assessment of Telomerase Reverse Transcriptase Single Nucleotide Polymorphism in Sleep Bruxism. Journal of clinical medicine 11 (3) (2022)
Justyna Joanna Gleba, Dagmara Klopotowska, Joanna Banach, Eliza Turlej, Karolina Anna Mielko, Katarzyna Górna, Katarzyna Bogunia-Kubik, Andrzej Kutner, Joanna Wietrzyk
Polymorphism of VDR Gene and the Sensitivity of Human Leukemia and Lymphoma Cells to Active Forms of Vitamin D. Cancers 14 (2) (2022)
Milena Iwaszko, Sylwia Biały, Katarzyna Bogunia-Kubik
Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis. Cells 10 (11) (2021)
Jagoda Siemaszko, Aleksandra Marzec-Przyszlak, Katarzyna Bogunia-Kubik
NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications. Cells 10 (6) (2021)
Joanna Wielinska, Jerzy Świerkot, Katarzyna Kolossa, Bartosz Bugaj, Monika Chaszczewska-Markowska, Sławomir Jeka, Katarzyna Bogunia-Kubik
Polymorphisms within Genes Coding for IL-17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis. Mediators of inflammation 2021 (2021)
Joanna Wielinska, Rachel E Crossland, Piotr Łacina, Jerzy Świerkot, Bartosz Bugaj, Anne M Dickinson, Katarzyna Bogunia-Kubik
Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors. Disease markers 2021 (2021)
Monika Kosacka, Tomasz Dyła, Monika Chaszczewska-Markowska, Katarzyna Bogunia-Kubik, Anna Brzecka
Decreased Thrombospondin-1 and Bone Morphogenetic Protein-4 Serum Levels as Potential Indices of Advanced Stage Lung Cancer. Journal of clinical medicine 10 (17) (2021)
Joanna Wielinska, Katarzyna Bogunia-Kubik
miRNAs as potential biomarkers of treatment outcome in rheumatoid arthritis and ankylosing spondylitis. Pharmacogenomics 22 (5) (2021)
Piotr Łacina, Aleksandra Butrym, Michał Humiński, Marta Dratwa, Diana Frontkiewicz, Grzegorz Mazur, Katarzyna Bogunia-Kubik
Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma. Molecular carcinogenesis 60 (2) (2020)
Katarzyna Bogunia-Kubik, Piotr Łacina
Non-KIR NK cell receptors: Role in transplantation of allogeneic haematopoietic stem cells. International journal of immunogenetics 48 (2) (2020)
Joanna Wielińska, Katarzyna Kolossa, Jerzy Świerkot, Marta Dratwa, Milena Iwaszko, Bartosz Bugaj, Barbara Wysoczańska, Monika Chaszczewska-Markowska, Sławomir Jeka, Katarzyna Bogunia-Kubik
Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment. Archivum immunologiae et therapiae experimentalis 68 (4) (2020)
J Wielińska, M Dratwa, J Świerkot, L Korman, M Iwaszko, B Wysoczańska, Katarzyna Bogunia-Kubik
Interleukin 6 gene polymorphism is associated with protein serum level and disease activity in Polish patients with rheumatoid arthritis. HLA (2019)